To determine whether adding recombinant erythropoietin to the intravenous (IV) solution and administering it as a 24-h continuous infusion would result in an erythropoietic effect not inferior to that seen with subcutaneous (SC) administration.
Costa, S., Romagnoli, C., Zuppa, A. A., Cota, F., Scorrano, A., Gallini, F., Maggio, L., How to administrate erythropoietin, intravenous or subcutaneous?, <<ACTA PAEDIATRICA>>, 2013; 102 (6): 579-583. [doi:10.1111/apa.12193] [http://hdl.handle.net/10807/52058]
How to administrate erythropoietin, intravenous or subcutaneous?
Costa, Simonetta;Romagnoli, Costantino;Zuppa, Antonio Alberto;Cota, Francesco;Gallini, Francesca;Maggio, Luca
2013
Abstract
To determine whether adding recombinant erythropoietin to the intravenous (IV) solution and administering it as a 24-h continuous infusion would result in an erythropoietic effect not inferior to that seen with subcutaneous (SC) administration.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
